Evidence map›Paper›PMID 40635410›Full record

ArticlePhysiological reports2025

Intermuscular adipose tissue and muscle function in patients on maintenance hemodialysis.

R Gulsah Dilaver, Mert Demirci, Rachelle Crescenzi, Michael Pridmore, Lale A Ertuglu, Andrew Guide, Robert Greevy, Baback Roshanravan, T Alp Ikizler, Jorge L Gamboa

Abstract read
In one paragraph

Article in Physiological reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Intermuscular Adipose Tissue in CKD: A Window into Muscle Quality and Health?Clinical journal of the American Society of Nephrology : CJASN · 2025
    Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

R Gulsah DilaverDepartment of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-0730-7641
Mert DemirciDepartment of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Rachelle CrescenziDepartment of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Michael PridmoreDepartment of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Lale A ErtugluDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Andrew GuideDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-5057-2424
Robert GreevyDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Baback RoshanravanDepartment of Medicine, Division of Nephrology University of California, Davis, Sacramento, California, USA.
T Alp IkizlerDepartment of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jorge L GamboaDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-4204-7670

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Postdoctoral Training in Biomedical MRI and MRST32EB001628 · NIBIB · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John C Gore · 2003 to 2026
$7.0M
Visualizing vascular mechanisms of lipedemaR01HL157378 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CRESCENZI, RACHELLE L · 2021 to 2025
$2.5M
Skeletal Muscle Mitochondrial Function in Chronic Kidney DiseaseR01DK101509 · NIDDK · UNIVERSITY OF WASHINGTON · PI KESTENBAUM, BRYAN R · 2015 to 2018
$2.5M
Imaging sodium and lymphatics in lymphedemaR01HL155523 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CRESCENZI, RACHELLE L · 2021 to 2025
$2.4M
CSRD VA I01 CX001755HHS | NIH | National Center for Advancing Translational Sciences (NCATS) UL1-TR000445HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 1R01HL155523HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 1R01HL157378HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01 DKDK125794NCATS NIH HHS UL1 TR000445NHLBI NIH HHS R01 HL155523NHLBI NIH HHS R01 HL157378NIBIB NIH HHS T32 EB001628NIDDK NIH HHS R01 DK101509U.S. Department of Veterans Affairs (VA) 5I01CX001755
6 · The paper itself

Abstract

Sarcopenia is common in advanced chronic kidney disease (CKD), contributing to poor outcomes. Intermuscular adipose tissue (IMAT) may worsen muscle function through metabolic and inflammatory pathways. We conducted a cross-sectional study comparing maintenance hemodialysis (MHD) patients and controls to assess IMAT and its associations. IMAT was measured via calf muscle MRI, and body composition (BMI, fat mass index), metabolic markers (hs-CRP, TNF-α, IL-6, insulin resistance), and circulating cell-free mitochondrial DNA (ccf-mtDNA) were assessed. Muscle function was evaluated with handgrip strength. IMAT differences between groups were tested using inverse propensity weighting. We analyzed 25 MHD patients and 23 controls. Median age was 53 years, BMI 30.4 kg/m

Indexed as

Adipose TissueMuscle, SkeletalRenal DialysisRenal Insufficiency, ChronicSarcopeniaAdultAgedBody CompositionCross-Sectional StudiesFemaleHand StrengthHumansInterleukin-6MaleMiddle AgedInterleukin-6chronic kidney diseasehemodialysisinflammationintermuscular adipose tissuephysical performance

Identifiers

PMID40635410
PMCPMC12241717

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.